The board of directors of the China NT Pharma Group Company Limited announced that based on a preliminary review of the Group's unaudited management accounts and the information currently available to the Board, the Board currently estimates that the Group will likely record a loss for the year ended 31 December 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 HKD | +4.00% |
|
+8.33% | -52.73% |
1st Jan change | Capi. | |
---|---|---|
-52.73% | 8.46M | |
+51.94% | 803B | |
-5.77% | 351B | |
+19.23% | 324B | |
+11.43% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.24% | 164B | |
-3.25% | 155B |
- Stock Market
- Equities
- 1011 Stock
- News China NT Pharma Group Company Limited
- China NT Pharma Group Company Limited Provides Group Earnings Guidance for the Full Year Ended 31 December 2013